Aratana Theraptcs
(PETX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Sales | 40 | 38,047 | 172 | 63 | 229 |
| Cost of Goods | 286 | 1,741 | 19 | 8 | 138 |
| Gross Profit | -246 | 36,306 | 153 | 55 | 91 |
| Operating Expenses | 12,654 | 15,087 | 17,432 | 12,344 | 55,236 |
| Operating Income | -12,614 | 21,960 | -17,260 | -12,281 | -55,007 |
| Interest Expense | 859 | 846 | 849 | 924 | 226 |
| Other Income | 102 | 82 | 42 | 41 | 33 |
| Pre-tax Income | -13,371 | 21,196 | -18,067 | -13,164 | -55,200 |
| Income Tax | N/A | N/A | N/A | -309 | -758 |
| Net Income Continuous | -13,371 | 21,196 | -18,067 | -12,855 | -54,442 |
| Net Income | $-13,371 | $21,196 | $-18,067 | $-12,855 | $-54,442 |
| EPS Basic Total Ops | -0.38 | 0.61 | -0.52 | -0.38 | -1.58 |
| EPS Basic Continuous Ops | -0.38 | 0.61 | -0.52 | -0.37 | -1.58 |
| EPS Diluted Total Ops | -0.38 | 0.61 | -0.52 | -0.38 | -1.58 |
| EPS Diluted Continuous Ops | -0.38 | 0.61 | -0.52 | -0.37 | -1.58 |
| EBITDA(a) | $-12,369 | $22,209 | $-17,016 | $-12,037 | $-54,467 |